Science & Technology Partners Portfolio holdings
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$26.8M |
| 2 |
Apple
AAPL
|
+$26.5M |
| 3 |
Aehr Test Systems
AEHR
|
+$22.8M |
| 4 |
Guardant Health
GH
|
+$22.7M |
| 5 |
Spire Global
SPIR
|
+$21.5M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Keysight
KEYS
|
+$29.1M |
| 2 |
Cloudflare
NET
|
+$22.8M |
| 3 |
TSMC
TSM
|
+$18.1M |
| 4 |
Lumentum
LITE
|
+$17.6M |
| 5 |
Bloom Energy
BE
|
+$17.1M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 49.1% |
| 2 | Healthcare | 26.96% |
| 3 | Industrials | 21.46% |
| 4 | Financials | 2.27% |
| 5 | Communication Services | 0.21% |
Similar funds
Science & Technology Partners's Q2 2026 Portfolio in Review
As of Q2 2026, Science & Technology Partners held 104 positions worth $593M, up 55% from $382M the previous quarter. Its ten largest holdings account for 48% of the portfolio.
Science & Technology Partners deployed $62.7M of net new capital in Q2 2026, opening 61 new positions and adding to 9 existing holdings. Its largest new stake was Aehr Test Systems: 249,000 shares worth $23.9M.
By sector, the portfolio is most concentrated in Technology at 49% of assets, down from 69% a quarter earlier, followed by Healthcare and Industrials.
On the sell side, the largest reduction was Keysight, an estimated $29.1M trimmed.
- Science & Technology Partners's largest Q2 2026 buy was Aehr Test Systems: 249,000 shares worth $23.9M.
- Science & Technology Partners added most to NVIDIA in Q2 2026, an estimated $26.8M increase.
- Science & Technology Partners's biggest Q2 2026 reduction was Keysight, cutting an estimated $29.1M.
- Science & Technology Partners fully exited TSMC in Q2 2026, selling an estimated $18.1M.
- Science & Technology Partners's ten largest holdings make up 48% of its $593M portfolio in Q2 2026.
- Science & Technology Partners opened 61 new positions and closed 20 in Q2 2026.
- Science & Technology Partners's portfolio value rose 55% quarter-over-quarter to $593M.
Based on Science & Technology Partners's 13F filing for Q2 2026, filed 14 Aug 2026.